Article info

Download PDFPDF

Original research
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people

Authors

  1. Correspondence to Prof Julia Hippisley-Cox, Primary Care Health Sciences, University of Oxford, Oxford OX1 2JD, UK; Julia.Hippisley-Cox{at}phc.ox.ac.uk
View Full Text

Citation

Hippisley-Cox J, Young D, Coupland C, et al
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people

Publication history

  • Received May 20, 2020
  • Revised July 8, 2020
  • Accepted July 13, 2020
  • First published July 31, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.